GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcyte Inc (FRA:5VA) » Definitions » Other Gross PPE

Vaxcyte (FRA:5VA) Other Gross PPE : €58.28 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Vaxcyte Other Gross PPE?

Vaxcyte's Other Gross PPE for the quarter that ended in Mar. 2024 was €58.28 Mil.

Vaxcyte's quarterly Other Gross PPE increased from Sep. 2023 (€31.98 Mil) to Dec. 2023 (€60.25 Mil) but then declined from Dec. 2023 (€60.25 Mil) to Mar. 2024 (€58.28 Mil).

Vaxcyte's annual Other Gross PPE increased from Dec. 2021 (€33.11 Mil) to Dec. 2022 (€33.74 Mil) and increased from Dec. 2022 (€33.74 Mil) to Dec. 2023 (€60.25 Mil).


Vaxcyte Other Gross PPE Historical Data

The historical data trend for Vaxcyte's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxcyte Other Gross PPE Chart

Vaxcyte Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial 5.25 5.46 33.11 33.74 60.25

Vaxcyte Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.05 36.90 31.98 60.25 58.28

Vaxcyte Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Vaxcyte (FRA:5VA) Business Description

Traded in Other Exchanges
Address
825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-XP, VAX-A1, and VAX-PG.

Vaxcyte (FRA:5VA) Headlines

No Headlines